C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4538-4547

  Meng, Xiangzhi ^a   Schoggins, John ^b   Rose, Lloyd ^a   Cao, Jingxin ^c   Ploss, Alexander ^b   Rice, Charles M ^b   Xiang, Yan ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERFERON; INTERFERON REGULATORY FACTOR 1;

ANTIVIRAL ACTIVITY; ARTICLE; C7L GENE; CAPRIPOXVIRUS; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INTERACTION; GROWTH CURVE; HOST RANGE; HUMAN; HUMAN CELL; INTERFERON STIMULATED GENE; K1L GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESIDUE ANALYSIS; SCREENING TEST; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SUIPOXVIRUS; VACCINIA VIRUS; VIRUS GENE; VIRUS REPLICATION; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CAPRIPOXVIRUS; CELL LINE; CERCOPITHECUS AETHIOPS; GENE ORDER; HOST SPECIFICITY; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE I; MICE; MOLECULAR SEQUENCE DATA; POXVIRIDAE; SEQUENCE ALIGNMENT; SUIPOXVIRUS; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

MAMMALIA; MURINAE; POXVIRIDAE; SHEEPPOX VIRUS; SWINEPOX VIRUS; VACCINIA VIRUS;

EID: 84861355891     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06140-11     Document Type: Article

References (22)

1. Arsenio J, Deschambault Y, Cao J. 2008. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells. Virology 377: 124-132.
2. Backes S, et al. 2010. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha. J. Gen. Virol. 91:470-482.
3. Beattie E, et al. 1996. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 12:89-94.
4. Fischer T, Planz O, Stitz L, Rziha H-J. 2003. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J. Virol. 77:9312-9323.
5. Hershkovitz D, et al. 2011. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J. Invest. Dermatol. 131:662-669.
6. Jones-Trower A, et al. 2005. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. Virology 343:128-140.
7. Li CF, et al. 2007. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics 8:92.
8. Li Y, Meng X, Xiang Y, Deng J. 2010. Structure-function studies of vaccinia virus host range protein k1 reveal a novel functional surface for ankyrin repeat proteins. J. Virol. 84:3331-3338.
9. Liu J, Wennier S, Zhang L, McFadden G. 2011. M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells. J. Virol. 85:3270-3282.
10. Matsuyama T, et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97.
11. McFadden G. 2005. Poxvirus tropism. Nat. Rev. Microbiol. 3:201-213
12. Meng X, Chao J, Xiang Y. 2008. Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L. Virology 372:372-383.
13. Meng X, et al. 2009. Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons. J. Virol. 83:10627-10636.
14. Meng X, Xiang Y. 2006. Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2. Virology 353:220-233.
15. Meng X, et al. 2011. Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus. Virology 409:271-279.
16. Moss B. 2007. Poxviridae: the viruses and their replication, p 2905-2946. In Knipe DM, et al (ed), Fields virology, Lippincott Williams and Wilkins, Philadelphia, PA.2
17. Perkus ME, et al. 1990. Vaccinia virus host range genes. Virology 179: 276-286.
18. Schoggins JW, et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
19. Sedgwick SG, Smerdon SJ. 1999. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24:311-316.
20. Tanaka M, Shimbo T, Kikuchi Y, Matsuda M, Kaneda Y. 2010. Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon. Int. J. Cancer 126:1982-1991.
21. Willis KL, Patel S, Xiang Y, Shisler JL. 2009. The effect of the vaccinia K1 protein on the PKR-eIF2alpha pathway in RK13 and HeLa cells. Virology 394:73-81.
22. Zhang L, Pagano JS. 1997. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell. Biol. 17:5748-5757.